Stable Clinical and MRI Response In Patients With Early Axial Spondyloarthritis After 3 Years Of Continuous Treatment With Etanercept, Data Of The Esther Trial

被引:0
作者
Song, In-Ho [1 ]
Hermann, Kay-Geert A. [1 ]
Haibel, Hildrun [1 ]
Althoff, Christian [1 ]
Poddubnyy, Denis [1 ]
Listing, Joachim [2 ]
Weiss, Anja [2 ]
Lange, Ekkehard [3 ]
Freundlich, Bruce [4 ]
Rudwaleit, Martin [5 ]
Sieper, Joachim [1 ]
机构
[1] Charite, D-13353 Berlin, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Pfizer Pharma AG, Berlin, Germany
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Endokrinologikum Berlin, Berlin, Germany
来源
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词
ANKYLOSING-SPONDYLITIS; SULFASALAZINE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1526
引用
收藏
页码:S647 / S648
页数:2
相关论文
共 4 条
  • [1] Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years
    Braun, J
    Baraliakos, X
    Brandt, J
    Listing, J
    Zink, A
    Alten, R
    Burmester, G
    Gromnica-Ihle, E
    Kellner, H
    Schneider, M
    Sörensen, H
    Zeidler, H
    Sieper, J
    [J]. RHEUMATOLOGY, 2005, 44 (05) : 670 - 676
  • [2] Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis
    Davis, J. C., Jr.
    van der Heijde, D. M.
    Braun, J.
    Dougados, M.
    Clegg, D. O.
    Kivitz, A. J.
    Fleischmann, R. M.
    Inman, R. D.
    Ni, L.
    Lin, S-L
    Tsuji, W. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) : 346 - 352
  • [3] Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial
    Song, I-H
    Hermann, K. G.
    Haibel, H.
    Althoff, C. E.
    Listing, J.
    Burmester, G. R.
    Krause, A.
    Bohl-Buehler, M.
    Freundlich, B.
    Rudwaleit, M.
    Sieper, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (04) : 590 - 596
  • [4] Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial
    Song, In-Ho
    Althoff, Christian E.
    Haibel, Hildrun
    Hermann, Kay-Geert A.
    Poddubnyy, Denis
    Listing, Joachim
    Weiss, Anja
    Djacenko, Svetlana
    Burmester, Gerd R.
    Bohl-Buehler, Martin
    Freundlich, Bruce
    Rudwaleit, Martin
    Sieper, Joachim
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (07) : 1212 - 1215